These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9242544)

  • 61. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A; Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pathophysiological effects of human TNF-alpha-producing tumor xenografts in immunosuppressed mice.
    Nagy T; Jánossy T; Vizler C; Bohus K; Joó F; Végh P; Duda E
    APMIS; 1999 Oct; 107(10):903-12. PubMed ID: 10549587
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Protective effect of N-acetyl-L-cysteine on liver and lung injury in mice after partial hepatic ischemia/reperfusion].
    Wu HS; Jin X; Tian Y; Zhang JH; Wang CY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):394-7. PubMed ID: 17631703
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suppression of growth and dissemination in human pre-B leukemia cells by tumor necrosis factor-alpha in scid mice.
    Yoshida N; Ishii E; Mohri S; Nagumo F; Yoshidomi S; Miyazaki S
    Leuk Lymphoma; 1999 Mar; 33(1-2):107-18. PubMed ID: 10194127
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TNF-mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide.
    Bilsborough J; Uyttenhove C; Colau D; Bousso P; Libert C; Weynand B; Boon T; van den Eynde BJ
    J Immunol; 2002 Sep; 169(6):3053-60. PubMed ID: 12218121
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transformed B cell lines express cell-associated tumor necrosis factor and mediate natural cytotoxic activity.
    Matsui NM; Patek PQ
    Cell Immunol; 1994 Apr; 154(1):358-68. PubMed ID: 8131208
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression.
    Faruqi RM; Poptic EJ; Faruqi TR; De La Motte C; DiCorleto PE
    Am J Physiol; 1997 Aug; 273(2 Pt 2):H817-26. PubMed ID: 9277499
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.
    Brunner C; Seiderer J; Schlamp A; Bidlingmaier M; Eigler A; Haimerl W; Lehr HA; Krieg AM; Hartmann G; Endres S
    J Immunol; 2000 Dec; 165(11):6278-86. PubMed ID: 11086063
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antitumor effect of DT-5461, a lipid A derivative, against human tumor xenografts is mediated by intratumoral production of tumor necrosis factor and affected by host immunosuppressive factors in nude mice.
    Kumazawa E; Jimbo T; Akimoto T; Joto N; Tohgo A
    Cancer Invest; 1997; 15(6):522-30. PubMed ID: 9412657
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis.
    Simon MM; Waring P; Lobigs M; Nil A; Tran T; Hla RT; Chin S; Müllbacher A
    J Immunol; 2000 Oct; 165(7):3663-72. PubMed ID: 11034370
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor necrosis factor-alpha modulates the expression of its p60 receptor and several cytokines in rat tracheal epithelial cells.
    Bader T; Nettesheim P
    J Immunol; 1996 Oct; 157(7):3089-96. PubMed ID: 8816419
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cells.
    Wang S; Wang Z; Dent P; Grant S
    Blood; 2003 May; 101(9):3648-57. PubMed ID: 12522001
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA; DeBenedette MA; Watts TH; Berinstein NL
    J Immunol; 1999 Apr; 162(8):5003-10. PubMed ID: 10202049
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.
    Kianmanesh A; Hackett NR; Lee JM; Kikuchi T; Korst RJ; Crystal RG
    Hum Gene Ther; 2001 Nov; 12(17):2035-49. PubMed ID: 11747595
    [TBL] [Abstract][Full Text] [Related]  

  • 77. N-acetyl-L-cysteine protects endothelial cells but not L929 tumor cells from tumor necrosis factor-alpha-mediated cytotoxicity.
    Schröder H; Warren S; Bargetzi MJ; Torti SV; Torti FM
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):664-6. PubMed ID: 8361551
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cyclosporin A/VP-16 produced immunity to L1210 leukemia: the participation of cytotoxic CD8 T-lymphocytes.
    Slater LM; Sweet P; Stupecky M; Reynolds JT
    Clin Immunol Immunopathol; 1995 Jun; 75(3):239-45. PubMed ID: 7768041
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.